Pieris Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Pieris Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-04-18 | $-0.04 | $-0.12 | 66.7 % |
Sep 2023 | 2023-11-14 | $-0.11 | $-0.11 | 0.00 % |
Jun 2023 | 2023-08-10 | $0.05 | $-0.16 | 131.3 % |
Mar 2023 | 2023-05-10 | $-0.18 | $-0.14 | -28.6 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-04-18 | $1.30M | $1.30M | -0.08 % |
Sep 2023 | 2023-11-14 | $19.52M | $7.74M | 152.2 % |
Jun 2023 | 2023-08-10 | $20.06M | $4.02M | 398.9 % |
Mar 2023 | 2023-05-10 | $1.94M | $6.50M | -70.2 % |
Pieris Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2024 for Q3.
Pieris Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2024 for Q3 and the Actual EPS was $-2.19, which missed the estimate of $0.00.
Pieris Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.